Ignite Creation Date:
2025-12-24 @ 10:40 PM
Ignite Modification Date:
2026-01-02 @ 10:22 PM
Study NCT ID:
NCT02846935
Status:
COMPLETED
Last Update Posted:
2019-01-07
First Post:
2016-07-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Refractory/Relapsed Lymphoid Malignancies
Sponsor:
Yogen Saunthararajah
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-04-25
Start Date Type:
ACTUAL
Primary Completion Date:
2018-01-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-01-22
Completion Date Type:
ACTUAL
First Submit Date:
2016-07-25
First Submit QC Date:
None
Study First Post Date:
2016-07-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-01-04
Last Update Post Date:
2019-01-07
Last Update Post Date Type:
ACTUAL